Effect of Carbohydrate Ingestion on Blood Glucose Concentration and Women’s Gymnastics Performance

2017 ◽  
Vol 11 (1) ◽  
pp. 13-28
Author(s):  
Trisha Rebrovich ◽  
Gary Babjack ◽  
Yomee Lee ◽  
James F. Hokanson
1992 ◽  
Vol 2 (4) ◽  
pp. 317-327 ◽  
Author(s):  
Randall L. Wilber ◽  
Robert J. Moffatt

Ten trained male runners performed a treadmill exercise test at 80%under two experimental conditions, carbohydrate (CHO, 7% carbohydrate) and placebo (P), to determine the effect of carbohydrate ingestion on endurance performance (treadmill run time), blood glucose concentration, respiratory exchange ratio (RER), and subjective ratings of perceived exertion (RPE). Treatment order was randomized and counterbalanced and test solutions were administered double-blind. Ingestion took place 5 min preexercise (250 ml) and at 15-min intervals during exercise (125 ml). Performance was enhanced by 29.4% (p~ 0.05) during CHO (115 ±25 min) compared to P (92 ± 27 min). Blood glucose concentration was significantly greater during CHO (5.6 ± 0.9 mM) relative to P (5.0 ±0.7 mM). There was a significant increase in mean RER following CHO ingestion (.94±.01) compared to P (.90±.01). Average RPE was significantly less during CHO (14.5±2.3) relative to P (15.4±2.4). These data suggest that time to exhaustion of high-intensity treadmill exercise is delayed as a result of carbohydrate ingestion and that this effect is mediated by favorable alterations in blood glucose concentration and substrate utilization.


2020 ◽  
Vol 79 (OCE2) ◽  
Author(s):  
David Archer ◽  
Craig Newby ◽  
Beth Allan ◽  
Leuenberger Thomas

AbstractExercise has many health benefits for individuals with Type 1 Diabetes (T1D), however it carries the risk of hypoglycaemia. Research has indicated that intermittent high intensity exercise reduces this risk compared to steady state exercise, potentially via a greater anaerobic component inducing increased lactate and catecholamine response.Six physically active males aged 23 ± 5 years, BMI 24.9 ± 1.8 kg•m-2, Vo2 max 47.9 ± 10.1 ml•kg-1•min-1 diagnosed with Type 1 Diabetes for 9 ± 3 years and a HbA1c concentration of 8.6 ± 0.3% participated in a randomised counterbalanced trial. Participants exercised for 60 min on a cycle ergometer on two occasions separated by 7 days, which consisted of a moderate continuous steady state exercise session at 40% o2 max (CONT), or the same exercise intensity interspersed with 7 s high intensity sprints at 100% Vo2 max every 2 min (INT). Blood glucose concentration was assessed via capillary blood sampling every 10 min during exercise and at regular intervals in the 60 min post exercise (Accu-Chek Aviva, Roche, UK). Additional metabolic measures such as blood lactate concentration and carbohydrate oxidation rates were assessed during exercise. Participants ingested small quantities of a carbohydrate drink, if required, to avoid hypoglycaemia during exercise. Magnitude based inferences were used to compare the two exercise trials and Effect Sizes (ES) calculated using Cohen's d and results presented as mean ± SD.Average blood glucose concentration was lower on the INT trial compared to CONT during both the exercise phase (8.9 ± 1.7 mmol•l-1 vs 7.1 ± 1.1 mmol•l-1; ES 0.55) and the 60 min post-exercise recovery phase (8.1 ± 1.9 mmol•l-1 vs 7.0 ± 1.8 mmol•l-1; ES 0.56). Carbohydrate oxidation was greater on the INT trial compared to CONT (1.9 ± 1.4 g•min-1 vs 1.5 ± 0.6 g•min-1; ES 0.35). Capillary blood lactate concentration was markedly elevated on INT when compared to CONT (5.0 ± 1.4 mmol•l-1 vs 2.4 ± 1.1 mmol•l-1; ES 2.48). Carbohydrate ingestion during exercise was 13 ± 11 g and differed little between trials (ES 0.18).Despite greater anaerobic metabolic response, the addition of intermittent high intensity sprints to 60 min steady-state cycle exercise resulted in greater declines in blood glucose concentration during the exercise and post-exercise period, potentially by inhibition of the counter regulatory hormone response expected on the INT trial. These results would indicate that additional exogenous carbohydrate ingestion may be required for individuals with T1D when intermittent sprints are added to prolonged continuous exercise.


2014 ◽  
Vol 307 (4) ◽  
pp. H587-H597 ◽  
Author(s):  
Mark W. Sims ◽  
James Winter ◽  
Sean Brennan ◽  
Robert I. Norman ◽  
G. André Ng ◽  
...  

While it is well established that mortality risk after myocardial infarction (MI) increases in proportion to blood glucose concentration at the time of admission, it is unclear whether there is a direct, causal relationship. We investigated potential mechanisms by which increased blood glucose may exert cardiotoxicity. Using a Wistar rat or guinea-pig isolated cardiomyocyte model, we investigated the effects on cardiomyocyte function and electrical stability of alterations in extracellular glucose concentration. Contractile function studies using electric field stimulation (EFS), patch-clamp recording, and Ca2+ imaging were used to determine the effects of increased extracellular glucose concentration on cardiomyocyte function. Increasing glucose from 5 to 20 mM caused prolongation of the action potential and increased both basal Ca2+ and variability of the Ca2+ transient amplitude. Elevated extracellular glucose concentration also attenuated the protection afforded by ischemic preconditioning (IPC), as assessed using a simulated ischemia and reperfusion model. Inhibition of PKCα and β, using Gö6976 or specific inhibitor peptides, attenuated the detrimental effects of glucose and restored the cardioprotected phenotype to IPC cells. Increased glucose concentration did not attenuate the cardioprotective role of PKCε, but rather activation of PKCα and β masked its beneficial effect. Elevated extracellular glucose concentration exerts acute cardiotoxicity mediated via PKCα and β. Inhibition of these PKC isoenzymes abolishes the cardiotoxic effects and restores IPC-mediated cardioprotection. These data support a direct link between hyperglycemia and adverse outcome after MI. Cardiac-specific PKCα and β inhibition may be of clinical benefit in this setting.


2014 ◽  
Vol 19 (3) ◽  
pp. 527-533 ◽  
Author(s):  
Miho Senda ◽  
Susumu Ogawa ◽  
Kazuhiro Nako ◽  
Masashi Okamura ◽  
Takuya Sakamoto ◽  
...  

Author(s):  
Li-Nong Ji ◽  
Li-Xin Guo ◽  
Li-Bin Liu

AbstractBlood glucose self-monitoring by individuals with diabetes is essential in controlling blood glucose levels. The International Organization for Standardization (ISO) introduced new standards for blood glucose monitoring systems (BGMS) in 2013 (ISO 15197: 2013). The CONTOUR PLUSThis study evaluated the accuracy and precision of CONTOUR PLUS BGMS in quantitative glucose testing of capillary and venous whole blood samples obtained from 363 patients at three different hospitals.Results of fingertip and venous blood glucose measurements by the CONTOUR PLUS system were compared with laboratory reference values to determine accuracy. Accuracy was 98.1% (96.06%–99.22%) for fingertip blood tests and 98.1% (96.02%–99.21%) for venous blood tests. Precision was evaluated across a wide range of blood glucose values (5.1–17.2 mmol/L), testing three blood samples repeatedly 15 times with the CONTOUR PLUS blood glucose meter using test strips from three lots. All within-lot results met ISO criteria (i.e., SD<0.42 mmol/L for blood glucose concentration <5.55 mmol/L; CV<7.5% for blood glucose concentration ≥5.55 mmol/L). Between-lot variations were 1.5% for low blood glucose concentration, 2.4% for normal and 3.4% for high.Accuracy of both fingertip and venous blood glucose measurements by the CONTOUR PLUS system was >95%, confirming that the system meets ISO 15197: 2013 requirements.


Sign in / Sign up

Export Citation Format

Share Document